The effects of MYO- Inositol and metformin on oxidative stress and homocysteine levels in patients with polycystic ovary syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190508043516N1

Enrollment

Registered

2019-07-28

Start date

2018-09-23

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome. Polycystic ovary syndrome

Interventions

Intervention 1: intervention group1: metformin twice a day at 850 mg for 3 months. Intervention 2: Intervention group2: 4 g of Myoinositol daily with 400 µg of folic acid (inofollic) for 3 months.

Eligibility

Sex/Gender

Female

Age

15 Years to 35 Years

Inclusion criteria

Inclusion criteria: Polycystic ovary syndrome

Exclusion criteria

Exclusion criteria: Diabetes mellitus Hyperprolactinemia Congenital adrenal hyperplasia Thyroid disorders Cushing's syndrome Liver and kidney disorders Hypertension Hemoglobinopathy

Design outcomes

Primary

Measure	Time frame
Homocysteine. Timepoint: Beginning of study, three months after the intervention. Method of measurement: Elisa kit.;Oxidative stress factors. Timepoint: Beginning of study, three months after the intervention. Method of measurement: Elisa kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasim athari

Dezfoul University of Medical Sciences

Atharinasim@yahoo.com+98 61 3446 2568

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 12, 2026